972 filings
Page 37 of 49
S-3/A
ACER
Acer Therapeutics Inc.
Shelf registration (amended)
30 Oct 09
12:00am
ARS
2008 FY
ACER
Acer Therapeutics Inc.
13 Oct 09
Annual report to shareholders
12:00am
S-3
ACER
Acer Therapeutics Inc.
Shelf registration
9 Oct 09
12:00am
EFFECT
ACER
Acer Therapeutics Inc.
6 Oct 09
Notice of effectiveness
12:00am
DEF 14A
ACER
Acer Therapeutics Inc.
Definitive proxy
2 Oct 09
12:00am
CORRESP
ACER
Acer Therapeutics Inc.
2 Oct 09
Correspondence with SEC
12:00am
DEFA14A
ACER
Acer Therapeutics Inc.
2 Oct 09
Additional proxy soliciting materials
12:00am
POS AM
ACER
Acer Therapeutics Inc.
25 Sep 09
Prospectus update (post-effective amendment)
12:00am
UPLOAD
ACER
Acer Therapeutics Inc.
22 Sep 09
Letter from SEC
12:00am
PRE 14A
ACER
Acer Therapeutics Inc.
Preliminary proxy
18 Sep 09
12:00am
POS AM
ACER
Acer Therapeutics Inc.
17 Sep 09
Prospectus update (post-effective amendment)
12:00am
CT ORDER
ACER
Acer Therapeutics Inc.
15 Sep 09
Confidential treatment order
12:00am
8-K
ACER
Acer Therapeutics Inc.
11 Sep 09
Regulation FD Disclosure
12:00am
8-K
ACER
Acer Therapeutics Inc.
10 Sep 09
Opexa Reports Additional Favorable Data with Tovaxin® for Multiple Sclerosis
12:00am
8-K
ACER
Acer Therapeutics Inc.
13 Aug 09
Opexa Therapeutics Reports Second Quarter 2009 Financial Resultsand Corporate Update
12:00am
10-Q
2009 Q2
ACER
Acer Therapeutics Inc.
Quarterly report
13 Aug 09
12:00am
8-K
ACER
Acer Therapeutics Inc.
10 Aug 09
Opexa Regains NASDAQ Compliance Following Stem Cell Agreement
12:00am
8-K
ACER
Acer Therapeutics Inc.
7 Aug 09
Other Events
12:00am
8-K
ACER
Acer Therapeutics Inc.
7 Aug 09
Opexa Announces Stem Cell Agreement with Leading Global Pharmaceutical Company
12:00am
8-K
ACER
Acer Therapeutics Inc.
9 Jun 09
Opexa Therapeutics Receives Favorable NASDAQ Determination
12:00am